Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,258 signal articles · 53 in last 24h · 115,243 total before filter · latest 56m ago
53last 24h
1810last 7d
299● bullish (7d)
171● bearish (7d)
205publishers
AllMacro323Earnings856M&A105Regulatory25Product16Analyst25
✕ clear all filtersticker: MRKSentiment:bullishneutralbearishshow all (incl. clickbait)
Organon & Co. Shareholders Clear Sun Pharma Merger Deal
MarketBeat23d agoneutral
Organon & Co. Shareholders Clear Sun Pharma Merger Deal

Shareholders of Organon & Co. (NYSE:OGN) approved the company’s proposed merger agreement with Sun Pharmaceutical Holdings USA, Inc. at a virtual special meeting held Wednesday, according to preliminary voting results announced during the meeting. The special meeting was convened solely to cons

Bio-Techne (TECH) Soars 20% on Merck $11.3B Merger
Insider Monkey50d agobullish
Bio-Techne (TECH) Soars 20% on Merck $11.3B Merger

Bio-Techne Corp. (NASDAQ:TECH) is one of the 9 Stocks Winning by Double Digits. Bio-Techne rallied for a third straight day on Thursday, surging 20.08 percent to close at $70.70 apiece, as investors gobbled up shares following news that it is merging with pharmaceutical giant Merck for $11.3 billion. In a statement, Bio-Techne Corp. (NASDAQ:TECH) said […]

How America Got to SpaceX: The Long Trail of Big IPOs That Began in 1783
Barrons.com59d agoneutral
How America Got to SpaceX: The Long Trail of Big IPOs That Began in 1783

SpaceX’s $75 billion initial public offering shattered market records, turned founder Elon Musk into the world’s first trillionaire, and opened fresh debates over corporate valuations and governance. It’s not the first time an IPO has shaken things up. IPOs have been reshaping markets since the Bank of North America’s 1783 debut got it all started for the young republic.